Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 100 Total
OC - Owens Corning - Stock Price Chart
TickerOC [NYSE]
CompanyOwens Corning
CountryUSA
IndustryBuilding Products & Equipment
Market Cap15.09BEPS (ttm)12.35
P/E14.10EPS this Y4.74%
Forward P/E10.92EPS next Y5.62%
PEG1.83EPS past 5Y21.79%
P/S1.56EPS next 5Y7.70%
P/B2.89EPS Q/Q-18.38%
Dividend1.38%Sales Q/Q-1.33%
Insider Own1.04%Inst Own93.48%
Insider Trans-4.81%Inst Trans-1.89%
Short Float1.85%EarningsApr 24/b
Analyst Recom2.24Target Price184.22
Avg Volume631.94K52W Range105.56 - 183.32
Owens Corning engages in the development, manufacture, and marketing of insulation, roofing, and fiberglass composites. It operates through the following segments: Composites, Insulation, and Roofing. The Composites segment manufactures, fabricates, and sells glass reinforcements in the form of fiber, and includes vertically integrated downstream activities. The Insulation segment provides insulating products which help customers conserve energy, provide improved acoustical performance, and offer convenience of installation and use. The Roofing segment offers laminate and strip asphalt roofing shingles and other products including oxidized asphalt and roofing accessories. The company was founded on October 31, 1938, and is headquartered in Toledo, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandri Marcio APresident, CompositesMay 24 '24Sale178.009,6971,726,06662,895May 29 04:11 PM
Del Monaco NicolasPresident, InsulationMay 21 '24Sale176.473,423604,05711,381May 23 04:54 PM
Mendez-Andino JoseEVP, Chief R&D OfficerMar 15 '24Sale156.722,833443,98814,814Mar 19 04:18 PM
Russell PaulaEVP, Chief HR OfficerMar 14 '24Sale162.003,765609,93020,419Mar 15 04:19 PM
Smith GunnerPresident, RoofingFeb 14 '24Sale148.997,4421,108,78436,140Feb 15 04:29 PM
VRTX - Vertex Pharmaceuticals, Inc. - Stock Price Chart
TickerVRTX [NASD, NDX, S&P 500]
CompanyVertex Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap113.83BEPS (ttm)15.41
P/E28.62EPS this Y11.15%
Forward P/E24.27EPS next Y7.35%
PEG2.28EPS past 5Y11.42%
P/S11.19EPS next 5Y12.53%
P/B6.14EPS Q/Q56.65%
Dividend-Sales Q/Q14.21%
Insider Own0.27%Inst Own92.79%
Insider Trans-17.30%Inst Trans1.21%
Short Float1.46%EarningsMay 06/a
Analyst Recom1.94Target Price466.23
Avg Volume1.06M52W Range320.01 - 457.66
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kewalramani ReshmaCEO & PresidentMay 24 '24Option Exercise187.531,565293,484122,939May 29 04:08 PM
Kewalramani ReshmaCEO & PresidentMay 24 '24Sale457.001,565715,205121,374May 29 04:08 PM
SACHS BRUCE IDirectorMay 22 '24Option Exercise93.517,073661,39647,073May 24 04:13 PM
SACHS BRUCE IDirectorMay 22 '24Sale448.007,0733,168,70440,000May 24 04:13 PM
Kewalramani ReshmaCEO & PresidentMay 20 '24Sale447.0015,2026,795,294121,374May 22 04:21 PM
LDI - LoanDepot Inc - Stock Price Chart
TickerLDI [NYSE]
CompanyLoanDepot Inc
CountryUSA
IndustryMortgage Finance
Market Cap318.95MEPS (ttm)-0.57
P/E-EPS this Y42.62%
Forward P/E10.46EPS next Y166.04%
PEG-EPS past 5Y6.34%
P/S0.32EPS next 5Y-
P/B0.99EPS Q/Q24.32%
Dividend-Sales Q/Q13.80%
Insider Own64.62%Inst Own12.95%
Insider Trans-1.39%Inst Trans0.60%
Short Float2.55%EarningsMay 07/a
Analyst Recom3.20Target Price2.45
Avg Volume404.77K52W Range1.14 - 3.71
loanDepot, Inc. engages in the business of originating, financing, selling, and servicing residential mortgage loans, title, escrow, and settlement services for mortgage loan transactions. It also offers a variety of loan products and in-house servicing platforms. The company was founded by Anthony Hsieh in December 2009 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hsieh Anthony LiDirectorMay 28 '24Sale1.8650,00093,0253,006,605May 29 04:06 PM
Hsieh Anthony LiDirectorMay 24 '24Sale1.9876,210150,5153,056,605May 29 04:06 PM
Hsieh Anthony LiDirectorMay 23 '24Sale2.02122,808248,5633,132,815May 23 06:52 PM
Hsieh Anthony LiDirectorMay 22 '24Sale2.0338,50478,0483,255,623May 23 06:52 PM
Hsieh Anthony LiDirectorMay 21 '24Sale2.05123,280252,4163,294,127May 22 04:18 PM
GEHC - GE HealthCare Technologies Inc - Stock Price Chart
TickerGEHC [NASD, NDX, S&P 500]
CompanyGE HealthCare Technologies Inc
CountryUSA
IndustryHealth Information Services
Market Cap35.81BEPS (ttm)3.43
P/E22.90EPS this Y8.86%
Forward P/E16.45EPS next Y11.49%
PEG1.99EPS past 5Y-2.54%
P/S1.84EPS next 5Y11.50%
P/B4.83EPS Q/Q97.00%
Dividend0.08%Sales Q/Q-1.21%
Insider Own7.03%Inst Own75.28%
Insider Trans-0.28%Inst Trans-
Short Float2.44%EarningsApr 30/b
Analyst Recom1.75Target Price93.61
Avg Volume3.04M52W Range62.35 - 94.50
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kass-Hout TahaChief Technology OfficerMay 28 '24Sale78.703,300259,71067,300May 29 04:05 PM
Makela JanCEO, ImagingMay 15 '24Option Exercise74.3566,9554,978,229130,303May 15 07:15 PM
Makela JanCEO, ImagingMay 15 '24Sale81.5466,9555,459,51163,348May 15 07:15 PM
Makela JanCEO, ImagingMay 13 '24Option Exercise63.5120,2271,284,61783,575May 15 07:15 PM
Makela JanCEO, ImagingMay 13 '24Sale81.5720,2271,649,91663,348May 15 07:15 PM
RNG - RingCentral Inc. - Stock Price Chart
TickerRNG [NYSE]
CompanyRingCentral Inc.
CountryUSA
IndustrySoftware - Application
Market Cap3.18BEPS (ttm)-1.48
P/E-EPS this Y12.21%
Forward P/E8.32EPS next Y14.49%
PEG-EPS past 5Y-39.50%
P/S1.41EPS next 5Y-
P/B-EPS Q/Q46.17%
Dividend-Sales Q/Q9.47%
Insider Own12.86%Inst Own88.78%
Insider Trans-4.18%Inst Trans0.70%
Short Float5.52%EarningsMay 07/a
Analyst Recom2.22Target Price39.94
Avg Volume1.01M52W Range25.08 - 43.28
RingCentral, Inc. engages in the provision of global enterprise cloud communications and collaboration solutions. The firm's solutions provide a single user identity across multiple locations and devices, including smartphones, tablets, PCs and desk phones, and allows for communication across multiple modes, including high-definition voice, video, SMS, messaging and collaboration, conferencing, online meetings and fax. It sells its products under the RingCentral Professional, RingCentral Glip, and RingCentral Fax brands. The company was founded by Vlad Vendrow and Vladimir Shmunis in 1999 and is headquartered in Belmont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parekh Sonalee ElizabethCHIEF FINANCIAL OFFICERMay 28 '24Sale34.858,478295,433388,919May 29 04:05 PM
Shmunis VladimirCEO and ChairmanMay 22 '24Sale35.5232,0131,137,237635,969May 23 04:05 PM
Marlow John HSVP, CAO & GENERAL COUNSELMay 22 '24Sale35.5214,228505,389411,040May 23 04:05 PM
Shmunis VladimirCEO and ChairmanMay 21 '24Sale35.9266,5302,389,817667,982May 23 04:05 PM
Marlow John HSVP, CAO & GENERAL COUNSELMay 21 '24Sale35.9219,497700,334425,268May 23 04:05 PM
ABNB - Airbnb Inc - Stock Price Chart
TickerABNB [NASD, NDX, S&P 500]
CompanyAirbnb Inc
CountryUSA
IndustryTravel Services
Market Cap93.07BEPS (ttm)7.46
P/E19.64EPS this Y-37.56%
Forward P/E28.65EPS next Y13.20%
PEG1.06EPS past 5Y-
P/S9.09EPS next 5Y18.60%
P/B11.81EPS Q/Q132.07%
Dividend-Sales Q/Q17.82%
Insider Own32.33%Inst Own53.07%
Insider Trans-1.55%Inst Trans-1.19%
Short Float3.11%EarningsMay 08/a
Analyst Recom2.76Target Price151.26
Avg Volume4.19M52W Range103.74 - 170.10
Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALOGH ARISTOTLE NChief Technology OfficerMay 28 '24Sale146.0060087,600211,774May 29 04:05 PM
BALOGH ARISTOTLE NChief Technology OfficerMay 21 '24Sale145.7160087,426212,374May 22 05:26 PM
BALOGH ARISTOTLE NChief Technology OfficerMay 14 '24Sale149.4060089,640219,304May 16 04:05 PM
BALOGH ARISTOTLE NChief Technology OfficerMay 07 '24Sale162.0060097,200219,904May 09 04:05 PM
BALOGH ARISTOTLE NChief Technology OfficerApr 30 '24Sale161.0260096,612220,504May 02 04:05 PM
TENB - Tenable Holdings Inc - Stock Price Chart
TickerTENB [NASD, RUT]
CompanyTenable Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap5.06BEPS (ttm)-0.58
P/E-EPS this Y37.69%
Forward P/E31.81EPS next Y21.38%
PEG-EPS past 5Y13.22%
P/S6.12EPS next 5Y44.70%
P/B14.17EPS Q/Q44.51%
Dividend-Sales Q/Q14.36%
Insider Own1.71%Inst Own91.89%
Insider Trans-20.77%Inst Trans0.77%
Short Float3.03%EarningsMay 01/a
Analyst Recom1.65Target Price58.58
Avg Volume813.24K52W Range33.85 - 53.50
Tenable Holdings, Inc. engages in the development of security software solutions. It offers Cyber Exposure which is a discipline for managing and measuring cybersecurity risk in the digital era. Its products include tenable.io, tenable.sc, tenable.ot, and nessus professional. The firm delivers solutions in the field of application security, cloud security, compliance, energy, finance, healthcare, and retail. The company was founded by John C. Huffard, Jr. and Renaud M. Deraison in 2002 and is headquartered in Columbia, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Howe Niloofar RaziDirectorMay 28 '24Option Exercise0.003,309019,170May 28 07:17 PM
Thurmond Mark C.Chief Operating OfficerMay 28 '24Sale43.9794941,72832,906May 29 04:04 PM
Yoran AmitPresident, CEO and ChairmanMay 24 '24Sale43.485,684247,140374,922May 28 07:17 PM
Vintz Stephen AChief Financial OfficerMay 24 '24Sale43.483,418148,615268,200May 28 07:17 PM
Thurmond Mark C.Chief Operating OfficerMay 24 '24Sale43.343,381146,53333,855May 28 07:17 PM
PODD - Insulet Corporation - Stock Price Chart
TickerPODD [NASD, S&P 500]
CompanyInsulet Corporation
CountryUSA
IndustryMedical Devices
Market Cap12.06BEPS (ttm)3.31
P/E52.09EPS this Y5.21%
Forward P/E46.01EPS next Y21.04%
PEG3.50EPS past 5Y122.47%
P/S6.78EPS next 5Y14.90%
P/B15.25EPS Q/Q116.08%
Dividend-Sales Q/Q23.35%
Insider Own0.85%Inst Own100.89%
Insider Trans-2.45%Inst Trans-0.62%
Short Float6.14%EarningsMay 09/a
Analyst Recom1.42Target Price232.62
Avg Volume875.05K52W Range125.82 - 298.95
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scannell Timothy JDirectorMay 28 '24Option Exercise32.3318,267590,59545,886May 29 04:04 PM
Scannell Timothy JDirectorMay 28 '24Sale180.903,300596,97042,586May 29 04:04 PM
Petrovic ShaceyDirectorFeb 28 '24Option Exercise92.1111,6091,069,30514,176Feb 29 04:37 PM
Petrovic ShaceyDirectorFeb 28 '24Sale162.9211,6091,891,3382,567Feb 29 04:37 PM
BORIO LUCIANADirectorDec 15 '23Sale207.087214,9102,278Dec 18 04:01 PM
FANG - Diamondback Energy Inc - Stock Price Chart
TickerFANG [NASD, NDX, S&P 500]
CompanyDiamondback Energy Inc
CountryUSA
IndustryOil & Gas E&P
Market Cap34.78BEPS (ttm)17.74
P/E10.99EPS this Y5.20%
Forward P/E9.21EPS next Y11.75%
PEG2.07EPS past 5Y16.56%
P/S3.99EPS next 5Y5.30%
P/B2.05EPS Q/Q10.04%
Dividend4.59%Sales Q/Q15.69%
Insider Own0.52%Inst Own91.58%
Insider Trans-14.92%Inst Trans-0.34%
Short Float2.85%EarningsApr 30/a
Analyst Recom1.54Target Price225.96
Avg Volume1.44M52W Range119.38 - 210.83
Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wesson Daniel NExec. VP & COOMay 28 '24Sale197.146,0001,182,84469,677May 29 04:02 PM
Zmigrosky MattEVP, Chief Legal and Admin OffMay 17 '24Sale198.156,0001,188,88438,445May 20 04:14 PM
Van't Hof Matthew KaesPresident & CFOMay 16 '24Sale195.6925,0004,892,312160,882May 20 04:13 PM
Thompson Jere W IIIExec. VP - Strategy & Corp DevMay 03 '24Sale199.90900179,9107,585May 07 04:06 PM
Stice Travis D.Chief Executive OfficerApr 02 '24Sale200.0030,0006,000,060446,610Apr 04 04:34 PM
REGN - Regeneron Pharmaceuticals, Inc. - Stock Price Chart
TickerREGN [NASD, NDX, S&P 500]
CompanyRegeneron Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap106.48BEPS (ttm)33.85
P/E28.55EPS this Y0.73%
Forward P/E20.44EPS next Y7.20%
PEG2.88EPS past 5Y10.31%
P/S8.13EPS next 5Y9.90%
P/B3.95EPS Q/Q-12.56%
Dividend-Sales Q/Q-0.54%
Insider Own3.63%Inst Own85.57%
Insider Trans-6.02%Inst Trans-0.34%
Short Float1.53%EarningsMay 02/b
Analyst Recom1.86Target Price1060.27
Avg Volume440.30K52W Range684.80 - 998.33
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWN MICHAEL SDirectorMay 28 '24Option Exercise625.601,172733,2032,554May 29 04:01 PM
BROWN MICHAEL SDirectorMay 28 '24Sale974.861,1721,142,5361,382May 29 04:01 PM
LAROSA JOSEPH JEVP General Counsel and SecretMay 21 '24Sale994.901,8651,855,48834,678May 22 04:02 PM
SCHLEIFER LEONARD SBd. Co-Chair, President & CEOMay 17 '24Sale979.2322,83022,355,714466,877May 17 05:57 PM
YANCOPOULOS GEORGEBd. Co-Chair, President & CSOMay 16 '24Sale972.7350,00048,636,545786,383May 17 04:06 PM
12345678910